Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 86 results for "dusa pharmaceuticals"

Sun Pharma To Acquire GSK's Australian Opiates Business

Dilip Sanghvi led Sun Pharmaceutical Industries is acquiring GlaxoSmithKline's Australian opiates business. The financial details of the deal remain undisclosed. The buy consists of two manufacturing sites, one each in Latrobe (Tasmania) and Port ... Deal Curry, 2 days ago

Dilip Shanghvi makes big investments in power, banking

MUMBAI: Dilip Shantilal Shanghvi, the world's richest pharma tycoon and Sun Pharma managing director, is increasingly expanding his business empire into new and diverse areas, making big investments in areas such as renewable energy and payment ...
 Economic Times2 weeks ago
Business Standard India

Suzlon rises over Shanghvi 'interest' in energy assets

Sun Pharma dismisses buzz; Suzlon up over three per cent Digbijay Mishra & Shreya Jai | New Delhi February 3, 2015 Last Updated at 00:49 IST Shares of Suzlon rose over three per cent today on speculation that Dilip Shanghvi of Sun Pharmaceuticals ...
 Business Standard India1 month ago

Generic Drugs a $350 Billion Opportunity According to 'The Generic Drugs Market: 2015-2030 - Opportunities, Challenges, Strategies & Forecasts'

A generic drug is a pharmaceutical product, usually intended to be interchangeable with an innovator product, that is manufactured without a license from the innovator company and marketed after the expiry date of the patent or other exclusive ...
 Morningstar.com2 days ago The Generic Drugs Market: 2015 - 2030 - Opportunities, Challenges, Strategies & Forecasts  Pharmacy Choice1 week ago The Generic Drugs Market: 2015 2030 - Opportunities, Challenges, Strategies & Forecasts  Research and Markets2 weeks ago
[x]  

Sun Pharma And Ranbaxy: An Ideal Pharma Marriage?

The boards of India's two leading pharmaceutical companies, Sun Pharmaceuticals and RanbaxyLaboratories, announced their merger in April 2014. In what is touted to be one of the biggest M&A deals in the Indian market, estimated at US$4 billion, Sun ...
 Investopedia6 days ago
EuroInvestor

Summit Therapeutics Appoints Mr David Wurzer as a Non-Executive Director

Summit Therapeutics plc ('Summit' or the 'Company') SUMMIT APPOINTS MR DAVID WURZER AS NON-EXECUTIVE DIRECTOR Oxford, UK, 23 February 2015 - Summit Therapeutics plc (AIM: SUMM), the drug discovery and development company advancing therapies ...
 EuroInvestor1 week ago Summit Therapeutics plc Summit Therapeutics Appoints Mr David Wurzer As A Non-Executive Director  ADVFN UK1 week ago IP : Summit Therapeutics plc - Summit Therapeutics Appoints Mr David Wurzer  4 Traders1 week ago Summit Therapeutics plc - Summit Therapeutics Appoints Mr David Wurzer  Noodls1 week ago
[x]  

Dilip Shanghvi's Net Worth: How Did He Get So Rich?

The second richest person in India, the seventh richest self-made billionaire in Asia and the richest person in the healthcare industry with a net worth of approximately US$18 billion -- all these adjectives can be used to describe Mr. Dilip ...
 Investopedia1 month ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - dusa pharmaceuticals
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less